Wilkinson-Berka JL - Search Results

1

Angiotensin II and aldosterone in retinal vasculopathy and inflammation.

Wilkinson-Berka JL, Suphapimol V, Jerome JR, Deliyanti D, Allingham MJ. Wilkinson-Berka JL, et al. Exp Eye Res. 2019 Oct;187:107766. doi: 10.1016/j.exer.2019.107766. Epub 2019 Aug 16. Exp Eye Res. 2019. PMID: 31425690 Review.

2

Retinal neovascularization is prevented by blockade of the renin-angiotensin system.

Moravski CJ, Kelly DJ, Cooper ME, Gilbert RE, Bertram JF, Shahinfar S, Skinner SL, Wilkinson-Berka JL. Moravski CJ, et al. Hypertension. 2000 Dec;36(6):1099-104. doi: 10.1161/01.hyp.36.6.1099. Hypertension. 2000. PMID: 11116132

3

Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes.

Gilbert RE, Kelly DJ, Cox AJ, Wilkinson-Berka JL, Rumble JR, Osicka T, Panagiotopoulos S, Lee V, Hendrich EC, Jerums G, Cooper ME. Gilbert RE, et al. Diabetologia. 2000 Nov;43(11):1360-7. doi: 10.1007/s001250051539. Diabetologia. 2000. PMID: 11126403

4

The interaction between the renin-angiotensin system and vascular endothelial growth factor in the pathogenesis of retinal neovascularization in diabetes.

Wilkinson-Berka JL, Kelly DJ, Gilbert RE. Wilkinson-Berka JL, et al. J Vasc Res. 2001 Nov-Dec;38(6):527-35. doi: 10.1159/000051088. J Vasc Res. 2001. PMID: 11740151 Review.

5

The renin-angiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic considerations.

Gilbert RE, Krum H, Wilkinson-Berka J, Kelly DJ. Gilbert RE, et al. Diabet Med. 2003 Aug;20(8):607-21. doi: 10.1046/j.1464-5491.2003.00979.x. Diabet Med. 2003. PMID: 12873287 Review.

6

Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin.

Sarlos S, Rizkalla B, Moravski CJ, Cao Z, Cooper ME, Wilkinson-Berka JL. Sarlos S, et al. Am J Pathol. 2003 Sep;163(3):879-87. doi: 10.1016/S0002-9440(10)63448-7. Am J Pathol. 2003. PMID: 12937129 Free PMC article.

7

Diabetes and retinal vascular disorders: role of the renin-angiotensin system.

Wilkinson-Berka JL. Wilkinson-Berka JL. Expert Rev Mol Med. 2004 Jul 23;6(15):1-18. doi: 10.1017/S1462399404008129. Expert Rev Mol Med. 2004. PMID: 15387897 Review.

8

Angiotensin and bradykinin: targets for the treatment of vascular and neuro-glial pathology in diabetic retinopathy.

Wilkinson-Berka JL, Fletcher EL. Wilkinson-Berka JL, et al. Curr Pharm Des. 2004;10(27):3313-30. doi: 10.2174/1381612043383179. Curr Pharm Des. 2004. PMID: 15544518 Review.

9

The renin-angiotensin system and the developing retinal vasculature.

Sarlos S, Wilkinson-Berka JL. Sarlos S, et al. Invest Ophthalmol Vis Sci. 2005 Mar;46(3):1069-77. doi: 10.1167/iovs.04-0885. Invest Ophthalmol Vis Sci. 2005. PMID: 15728567

10

Dysfunction of retinal neurons and glia during diabetes.

Fletcher EL, Phipps JA, Wilkinson-Berka JL. Fletcher EL, et al. Clin Exp Optom. 2005 May;88(3):132-45. doi: 10.1111/j.1444-0938.2005.tb06686.x. Clin Exp Optom. 2005. PMID: 15926876 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters